Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors

Cancer Immunology Immunotherapy

Volumn 42, Issue 1, 1996, Pages 9-14

  Sahin, Ugur ^a   Kraft Bauer, Sylvia ^a   Ohnesorge, Sascha ^a   Pfreundschuh, Michael ^a   Renner, Christoph ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Bispecific antibodies; Colorectal carcinoma; Hodgkin's Disease; IL 12

Indexed keywords

BISPECIFIC ANTIBODY; CD16 ANTIGEN; CD30 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; ANTIGENS, NEOPLASM; CALCIUM; COLORECTAL NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; EVALUATION STUDIES; HODGKIN DISEASE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; RECEPTORS, IGG; TUMOR CELLS, CULTURED;

EID: 0030031549     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050245     Document Type: Article

References (27)

1. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A (1994) Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84: 2261
2. Alonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235
3. Aste-Amezaga M, D'Andrea A, Kubin M, Tinchieri G (1994) Cooperation of natural killer cell stimulatory factor/interleukin 12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 156: 480
4. Blomberg K, Ulfstedt AC (1993) Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J Immunol Methods 160: 27
5. Bolhuis RL, Braakman E (1988) Lymphocyte mediated responses: activation of, and lysis by, cytotoxic lymphocytes. Curr Opin Immunol 1: 236
6. Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT, Leibson PJ (1994) Cytokine enhanced NK cell-mediated cytotoxicity: positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J Immunol 152: 2098
7. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayshi M, Perusia B, Young D, Nickbarg E, Wolf SF and Trinchieri G (1992) Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175: 789
8. Hall SS (1994) IL-12 holds promise against cancer, glimmer of AIDS hope. Science 263: 1685
9. Hersey P, Bolhuis RL (1990) MHC unrestricted killing by T cells - multireceptor hypothesis. Immunol Today 11: 110
10. Hombach A, Jung W, Pohl C, Renner C, Sahin U, Schmits R, Wolf J, Kapp U, Diehl V, Pfreundschuh M (1993) A CD16/CD30 bispecific antibody induces lysis of Hodgkin cells by unstimulated natural killer cells in vitro and in vivo. Int J Cancer 55: 830
11. Huizinga TW, School CE van der, Jost C, Klaassen R, Kleijer M, Borne A von dem, Roos D, Tetteroo P (1988) The PI-linked receptor for FcRIII is released on stimulation of neutrophils. Nature 333: 667
12. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Tinchieri G (1989) Identification an purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827
13. Lanier LL, Yu G and Philipps JH (1989) Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342: 803
14. Liao F, Shin HS, Rhee SG (1993) Cross-linking of FcγRIIIA on natural killer cells results in tyrosine phosphorylation of PLC-γ1 and PLC-γ2. J Immunol 150: 2668
15. Moretta A, Ciccone E, Pantaleo G, Tambussi G, Bottino C, Melioli G, Mingari MC, Moretta L (1989) Surface molecules involved on the activation and regulation of T or natural killer lymphocytes in humans. Immunol Rev 111: 145
16. Renner C, Jung W, Sahin U, Lier R van, Pfreundschuh M (1995) The role of lymphocyte subsets and adhesion molecules in T-cell dependent cytotoxicity mediated by CD3 and CD28 bispecific antibodies. Eur J Immunol 25: 2027
17. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue Ch, Young D, Herrmann SH, Ritz J (1992) Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175: 779
18. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR (1995) IL-12 reverses cytokine and immune abnormalities in Sézary syndrome. J Immunol 154: 1491
19. Scott P, Trinchieri G (1995) The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 7: 34
20. Selvaraj P, Rosse WF, Silber R, Springer T (1988) The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333: 565
21. Sirianni MC, Asotegui IJ, Aiuti F, Wigzell H (1994) Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type 1 infected patients. Scand J Immunol 40: 83
22. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82: 2790
23. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47: 187
24. 1 cells. Immunol Today 14: 335
25. Trinchieri G (1994) Recognition of major histocompatibility complex class I antigen by natural killer cells. J Exp Med 180: 417
26. Trinchieri G, Santoli D (1978) Antiviral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147: 1314
27. Wallace PK, Howell AL, Fanger MW (1994) Role of Fcγ receptors in cancer and infectious disease. J Leukoc Biol 55: 816